Mike Fedock
EVP and CFO at IQVIA
R&D Solutions revenue was $7,611,000,000, up 8% on a reported basis and 7.4% at constant currency. Now moving down the P&L. Third quarter adjusted EBITDA was $1,032,000,000, representing growth of 8.7% year-over-year, while year-to-date adjusted EBITDA was $2,958,000,000. In the quarter, adjusted EBITDA margins expanded by 20 basis points. Third quarter GAAP net income was $350,000,000, and GAAP diluted earnings per share was $2.10. Year-to-date, GAAP net income was $880,000,000, or $5.24 of earnings per diluted share. Third quarter adjusted net income was $557,000,000, and adjusted diluted earnings per share was $3.34, representing growth of 11.3% year-over-year. Year-to-date, adjusted net income was $1,576,000,000, or $9.38 per diluted share, up 10.4%. Now looking at R&D's bookings. The R&D Solutions net new bookings in the quarter were $3.2 billion, a 15% increase year-over-year, resulting in a 1.2 book-to-bill.